Of Patents And Production: Industry-White House Row Over Vaccine Exports Highlights Policy Divide
Executive Summary
BIO chief calls US Defense Production Act ‘misguided’ as India seeks more COVID vaccines; America will donate AstraZeneca vaccine – just as soon as the FDA determines it was adequately manufactured.
You may also be interested in...
Quick BIO CEO Departure Raises Questions About Direction For Next Leadership Pick
Michelle McMurry-Heath brought a science and regulatory background to the top post of the industry trade group in contrast to the political and lobbying focused careers of her predecessors. Her eventual successor may offer hints as to whether BIO thought that was a successful leadership strategy.
What Vexed Top Global Biopharmaceutical Executives About COVID-19 Response
Pfizer, Eli Lilly and Roche bosses say no country was perfect in its response to the coronavirus pandemic and there are lessons to be learnt.
Biden’s Vaccine Donation Plan Emphasizes American Production, Not IP Waivers
President announces ‘new effort’ to work with pharmaceutical companies, other nations to increase supply. Details remain in short supply, but Biden says plan will increase domestic production capacity to prepare ‘the next crises.’